Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STAR: Stereotactic Radiotherapy for Wet AMD
NCT02243878Phase 3Completed
- Sponsor
- King's College Hospital
- Start
- Dec 2014
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial (2 arms), sponsored by King's College Hospital. Primary endpoint: Number of as required (prn) ranibizumab injections at 24 months. Started Dec 2014; status: completed.
Beyond the preview
Go deeper on NCT02243878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02243878.